The abstract is read at the publisher; the summary is JClub's.
Pharmacological PI3K inhibition and the allosteric SHP2 inhibitor SHP099 rescue communicating hydrocephalus in Shp2C459S/+ mice, linked to ciliary defects and altered PI3K-AKT signaling.
- Why it matters: SHP2 mutations cause congenital hydrocephalus, but how catalytically inactive variants produce disease and whether conformation-targeted therapies can help is unclear.
- What they did: In engineered mice, Shp2C459S/+ uniquely disrupted ciliary development and motility, with elevated GAB1 and AKT phosphorylation in ventricular tissue; PI3K inhibition and SHP099 were tested, and SHP099 increased SHP2C459S thermal stability.
- The result: PI3K blockade markedly rescued ciliogenesis defects and alleviated hydrocephalus, while SHP099 shifted SHP2C459S toward a closed state and ameliorated hydrocephalus, supporting a conformation-driven mechanism.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.